KLK5, for instance, was reported to be downregulated in breast cancer,34 whereas elevated expression of KLK6, KLK7 and KLK10 has been associated with multiple cancers and poor prognosis in gastric and colorectal cancer.35–39. This evidence concerns the gene KLK5 and breast cancer.